» Articles » PMID: 31174090

Long Noncoding RNA BLACAT1 is Overexpressed in Hepatocellular Carcinoma and Its Downregulation Suppressed Cancer Cell Development Through Endogenously Competing Against Hsa-miR-485-5p

Overview
Date 2019 Jun 8
PMID 31174090
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: In this work, we explored the expression and mechanistic role of long noncoding RNA (lncRNA), bladder cancer associated transcript 1 (BLACAT1) in human hepatocellular carcinoma (HCC).

Methods: BLACAT1 expression in bothin vitro HCC cell lines and in vivo human HCC clinical samples were assessed by qRT-PCR. In HeG2 and MHCC97 L cells, BLACAT1 downregulation was induced by lentiviral infection to evaluate its functions in regulating HCC cancer cell proliferation and invasion in vitro, and xenograft in vivo. A BLACAT1 endogenously competing candidate, human microRNA-485-5p (has-miR-485-5p) was assessed in dual-luciferase assay and qRT-PCR in HCC cells. Furthermore, has-miR-485-5p was inhibited in BLACAT1-downregulated HeG2 and MHCC97 L cells to evaluate the correlation of has-miR-485-5p in BLACAT1-associated functional regulation in HCC cells.

Results: BLACAT1was found to be overexpressed in both HCC cells and human HCC tumors. In HeG2 and MHCC97 L cells, lentivirus-induced BLACAT1 downregulation inhibited cancer cellin vitro proliferation and invasion, and in vivo xenograft growth. Has-miR-485-5p was confirmed to be bound by BLACAT1 and its expression in HCC cells inversely regulated by BLACAT1. Then, has-miR-485-5p downregulation reversed the inhibitory effects of BLACAT1 downregulation on HCC cancer cell in vitro functions.

Conclusion: BLACAT1 is aberrantly upregulated in HCC and its inhibition had tumor suppressing effects in human HCC, possibly through endogenously competing against has-miR-485-5p. The BLACAT1/ has-miR-485-5p regulatory axis may be a molecular target for future HCC therapy.

Citing Articles

High expression of NXPH4 correlates with poor prognosis, metabolic reprogramming, and immune infiltration in colon adenocarcinoma.

Sun Z, Wang H, Xu Y, Liu Y, Wang L, Zhou R J Gastrointest Oncol. 2024; 15(2):641-667.

PMID: 38756632 PMC: 11094489. DOI: 10.21037/jgo-23-956.


lncRNA SNHG9 enhances liver cancer stem cell self-renewal and tumorigenicity by negatively regulating PTEN expression via recruiting EZH2.

Yang S, Ruan X, Hu B, Tu J, Cai H Cell Tissue Res. 2023; 394(3):441-453.

PMID: 37851112 DOI: 10.1007/s00441-023-03834-x.


The RNA interactome in the Hallmarks of Cancer.

Gabryelska M, Conn S Wiley Interdiscip Rev RNA. 2023; 14(5):e1786.

PMID: 37042179 PMC: 10909452. DOI: 10.1002/wrna.1786.


The Network of miRNA-mRNA Interactions in Circulating T Cells of Patients Following Major Trauma - A Pilot Study.

Rau C, Kuo P, Lin H, Wu C, Wu Y, Chien P J Inflamm Res. 2022; 15:5491-5503.

PMID: 36172547 PMC: 9512539. DOI: 10.2147/JIR.S375881.


Gut microbiome dysbiosis in patients with hepatitis B virus-related hepatocellular carcinoma after extended hepatectomy liver failure.

Peng Y, Xu J, Zeng C, Zhao X, Li L, Qi L Ann Transl Med. 2022; 10(10):549.

PMID: 35722392 PMC: 9201140. DOI: 10.21037/atm-22-1958.